Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P702: Off-label drug use in patients with inflammatory bowel disease: a national survey among tertiary care centres

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Simsek*1, F. Hoentjen2, B. Oldenburg3, C. Y. Ponsioen4, J. van der Woude5, A. E. van der Meulen6, M. Pierik7, G. Dijkstra8, N. K. de Boer1

1Amsterdam UMC, VU Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Radboud University Medical Center, Gastroenterology and Hepatology, Nijmegen, The Netherlands, 3University Medical Center Utrecht, Gastroenterology and Hepatology, Utrecht, The Netherlands, 4Amsterdam UMC, Academical Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 5Erasmus University Medical Center, Gastroenterology and Hepatology, Rotterdam, The Netherlands, 6Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, The Netherlands, 7Maastricht University Medical Center, Gastroenterology and Hepatology, Maastricht, The Netherlands, 8University Medical Center Groningen and University of Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands

P703: The real-world long-term effectiveness of vedolizumab in inflammatory bowel diseases: a single-centre observational study

ECCO '19 Copenhagen

Year: 2019
Authors:

F. S. Macaluso*1, A. Croce1, R. Orlando1, M. Ventimiglia1, C. Sapienza1, F. Gambino1, E. Orlando1, M. Grova1, G. Rizzuto1, S. Renna1, M. Cottone1, A. Orlando1

1IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy

P704: Association between trough levels of vedolizumab and therapy outcome in a cohort of patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

J. O'Connell1, P. McDonagh1, K. Hazel2, J. Fiona3, C. Dunne1,4, R. Farrell2, G. Harewood3, K. Hartery1,4, O. Kelly2, F. MacCarthy4,5, S. McKiernan1,4, F. Murray3, C. O'Morain6, O. Aoibhlinn3, D. Kevans1,4

1St James's Hospital, Department of Gastroenterology, Dublin, Ireland, 2Connolly Hospital Blanchardstown, Gastroenterology, Dublin, Ireland, 3Beaumont Hospital, Gastroenterology, Dublin, Ireland, 4INITIative, Investigator Network Inflammatory bowel disease Therapy in Ireland, Dublin, Ireland, 5St James's Hospital, Gastroenterology, Dublin, Ireland, 6Beacon Hospital, Gastroenterology, Dublin, Ireland

P705: Incidence and risk factors of micronutrient deficiency in the patients with inflammatory bowel disease in Korea: folate, vitamin B12, 25-OH-vitamin D, ferritin

ECCO '19 Copenhagen

Year: 2019
Authors:

Y. E. Park*1, S. J. Park2, Y. Park2, J. H. Cheon2, T. I. Kim2, W. H. Kim2

1Haeundae Paik Hospital, Division of Gastroenterology, Department of Internal Medicine, Busan, South Korea, 2Yonsei University College of Medicine, Seoul, Korea, Division of Gastroenterology, Department of Internal Medicine, Seoul, South Korea

P706: Patient knowledge towards biological treatment in inflammatory bowel diseases: a cross-sectional survey

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Wiśniewska-Jarosińska*1, M. Włodarczyk2, A. Gąsiorowska1, J. Fichna3, A. Sobolewska-Włodarczyk1

1Medical University of Lodz, Department of Gastroenterology, Lodz, Poland, 2Medical University of Lodz, Department of General and Colorectal Surgery, Lodz, Poland, 3Medical University of Lodz, Department of Biochemistry, Lodz, Poland

P707: 38 Weeks treatment of UC patients with different daily doses of mesalazine

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Laoun*1, R. Hofmann2

1Tillotts Pharma AG, Medical Affairs, Rheinfelden, Switzerland, 2Tillotts Pharma, Medicines Management, Rheinfelden, Switzerland

P708: Prospective study to predict psychological morbidity in young people with inflammatory bowel disease using novel risk assessment tool

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Hoogkamer*1, A. Brooks1, G. Rowse2, P. Norman2, A. Lobo1

1University of Sheffield, Academic Department of Gastroenterology, Sheffield, UK, 2University of Sheffield, Academic Department of Psychology, Sheffield, UK

P709: Early measurement of serum cytokines as predictor of clinical and endoscopic outcome to vedolizumab in patients with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Bertani*1, L. Antonioli2, L. Baglietto2, G. Tapete1, E. Albano1, M. G. Mumolo3, L. Ceccarelli3, S. Maltinti1, M. Fornai2, S. Marchi1, C. Blandizzi2, F. Costa3

1University of Pisa, Department of new technologies and translational sciences in medicine and surgery, Pisa, Italy, 2University of Pisa, Department of clinical and experimental medicine, Pisa, Italy, 3Pisa University Hospital, Department of General Surgery and Gastroenterology, Pisa, Italy

P710: The use of first-line biologics in patients with Crohn’s disease in Norway from 2011 to 2016

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Anisdahl*1,2, S. Lirhus3, A. Medhus1, L. Buer1,2, H. O. Melberg3, B. Moum1,2, M. Lie Høivik1

1Oslo University Hospital, Department of Gastroenterology, Oslo, Norway, 2University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 3University of Oslo, Institute of Health and Society, Oslo, Norway

P711: The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Amiot*1, M. Serrero2, L. Peyrin-Biroulet3, J. Filippi4, B. Pariente5, X. Roblin6, A. Buisson7, C. Stefanescu8, C. Trang-Poisson9, R. Altwegg10, P. Marteau11, T. Vaysse12, A. Bourrier13, S. Nancey14, D. Laharie15, M. Allez16, G. Savoye17, J. Moreau18, L. Vuitton19, S. Viennot20, A. Aubourg21, A-L. Pelletier22, G. Bouguen23, V. Abitbol24, M. Fumery25, C. Gagniere1, Y. Bouhnik8

1Henri Mondor Hospital, Gastroenterology, Creteil, France, 2Hopital Nord, Gastroenterology, Marseille, France, 3CHU Nancy, Gastroenterology, Nancy, France, 4CHU Nice, Gastroenterology, Nice, France, 5CHU Lille, Gastroenterology, Lille, France, 6CHU Saint-Etienne, Gastroenterology, Saint-Etienne, France, 7CHU Clermont-Ferrand, Gastroenterology, Clermont-Ferrand, France, 8CHU Beaujon, Gastroenterology, Clichy, France, 9CHU Nantes, Gastroenterology, Nantes, France, 10CHU Montpellier, Gastroenterology, Montpellier, France, 11CHU Lariboisiere, Gastroenterology, Paris, France, 12CHU Bicetre, Gastroenterology, Kremlin-Bicetre, France, 13CHU Saint-Antoine, Gastroenterology, Paris, France, 14CHU Lyon, Gastroenterology, Lyon, France, 15CHU Bordeaux, Gastroenterology, Bordeaux, France, 16CHU Saint-Louis, Gastroenterology, Paris, France, 17CHU Rouen, Gastroenterology, Rouen, France, 18CHU Toulouse, Gastroenterology, Toulouse, France, 19CHU Besancon, Gastroenterology, Besancon, France, 20CHU Caen, Gastroenterology, Caen, France, 21CHU Tours, Gastroenterology, Tours, France, 22CHU Bichat, Gastroenterology, Paris, France, 23CHU rennes, Gastroenterology, Rennes, France, 24CHU COchin, Gastroenterology, Paris, France, 25CHU Amiens, Gastroenterology, Amiens, France

P712: Tofacitinib efficacy in patients with moderate to severe ulcerative colitis: Subgroup analyses of OCTAVE Induction 1 and 2 and OCTAVE Sustain by 5-aminosalicylates use

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Hanauer1, D. T. Rubin2, P. Gionchetti3, C. Su4, D. A. Woodworth4, D. Quirk4, L. Salese4, W. Wang4, A. Marren4, N. Lawendy4, R. Panaccione*5

1Northwestern University, Feinberg School of Medicine, Chicago, IL, USA, 2University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA, 3University of Bologna, Department of Medical and Surgical Sciences (DIMEC), Bologna, Italy, 4Pfizer Inc., Collegeville, PA, USA, 5University of Calgary, Calgary, AB, Canada

P713: Long-term efficacy of endoscopic balloon dilatation using single-balloon enteroscopy in patients with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Takahashi*1, S. Bamba2, Y. Morita1, A. Nishida1, M. Sasaki2, T. Tsujikawa3, A. Andoh1

1Shiga University of Medical Science, Department of gastroenterology, Otsu, Japan, 2Shiga University of Medical Science, Division of Clinical Nutrition, Otsu, Japan, 3Shiga University of Medical Science, Department of Comprehensive Internal Medicine, Otsu, Japan

P714: Efficacy and safety of infliximab retreatment in luminal Crohn’s disease: a multi-centre, prospective, observational cohort (REGAIN) study

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Boschetti*1, B. Pariente2, D. Laharie3, X. Roblin4, C. Gilletta5, A. Aubourg6, A. Bourreille7, C. Zallot8, X. Hebuterne9, A. Buisson10, J-C. Grimaud11, Y. Bouhnik12, M. Allez13, R. Altwegg14, S. Viennot15, L. Vuitton16, F. Carbonnel17, M. Nachury2, S. Paul18, J. Lambert19, L. Peyrin-Biroulet8, Getaid1

1Lyon-Sud Hospital, Gastroenterology, Pierre Bénite, France, 2CHRU Lille, Gastroenterology, Lille, France, 3CHU Bordeaux, Gastroenterology, Bordeaux, France, 4CHU Saint-Etienne, Gastroenterology, Saint-Etienne, France, 5CHU Toulouse, Gastroenterology, Toulouse, France, 6CHU Tours, Gastroenterology, Tours, France, 7CHU Nantes, Gastroenterology, Nantes, France, 8CHU Nancy, Gastroenterology, Nancy, France, 9CHU Nice, Gastroenterology, Nice, France, 10CHU Clermont-Ferrand, Gastroenterology, Clermont-Ferrand, France, 11Assistance Publique-Hôpitaux de Marseille, Gastroenterology, Marseille, France, 12Beaujon Hospital, Gastroenterology, Paris, France, 13Saint-Louis Hospital, Gastroenterology, Paris, France, 14CHU Montpellier, Gastroenterology, Montpellier, France, 15CHU Caen, Gastroenterology, Caen, France, 16CHU Besançon, Gastroenterology, Besançon, France, 17Bicêtre Hospital, Gastroenterology, Le Kremlin-Bicêtre, France, 18CHU Saint-Etienne, Immunology, Saint-Etienne, France, 19Paris Diderot University, Paris, France

P715: Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Lair-Mehiri*1, C. Stefanescu1, T. Vaysse2, D. Laharie3, X. Roblin4, I. Rosa5, X. Treton1, V. Abitbol6, A. Amiot7, G. Bouguen8, N. Dib9, M. Fumery10, B. Pariente11, F. Carbonnel2, L. Peryn-Biroulet12, M. Simon13, S. Viennot14, Y. Bouhnik1

1APHP-Hôpital Beaujon, Department of Gastroenterology, Clichy, France, 2APHP-Hôpital Bicêtre, Department of Gastroenterology, Le Kremlin Bicêtre, France, 3Bordeaux University Hospital, Department of Gastroenterology, Bordeaux, France, 4Saint-Etienne University Hospital, Department of Gastroenterology, Saint Etienne, France, 5Intercommunal Creteil Hospital Center, Department of Gastroenterology, Créteil, France, 6AP-HP, Cochin Hospital, Department of Gastroenterology, Paris, France, 7AP-HP, Hôpital Henri Mondor, Department of Gastroenterology, Créteil, France, 8Rennes University Hospital, Department of Gastroenterology, Rennes, France, 9Angers University Hospital, Department of Gastroenterology, Angers, France, 10Amiens University Hospital, Department of Gastroenterology, Amiens, France, 11Lille University Hospital, Department of Gastroenterology, Lille, France, 12Nancy University Hospital, Department of Gastroenterology, Nancy, France, 13Institut Mutualiste Montsouris, Department of Gastroenterology, Paris, France, 14Caen University Hospital, Department of Gastroenterology, Caen, France

P716: The use of tacrolimus in patients with ulcerative colitis resistant to standard medical therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Shafi*1, A. Bedir2, L. Medcalf1, G. Chung-Faye1, B. Hope1, P. Dubois1, B. Hayee1, B. Vadamalayan1, A. J. Kent1

1King's College Hospital, London, UK, 2Basildon and Thurrock University Hospital, Essex, UK

P717: The use of combination biologic therapy in inflammatory bowel disease: A single tertiary-centre experience

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Panaccione*1, K. Novak1, C. Seow1, S. Devlin1, C. Lu1, J. Heatherington1, M-L. Martin1, G. Kaplan1, R. Panaccione1

1University of Calgary, Medicine, Calgary, Canada

P718: Risk of tuberculosis in patients with inflammatory bowel disease receiving biologics using two interferon-γ release assays as monitoring

ECCO '19 Copenhagen

Year: 2019
Authors:

R. de Francisco*1,2, M. Arias-Guillén3, A. Castaño-García1, I. Pérez-Martínez1, J. J. Palacios4, V. Rolle-Sóñora2, S. Martínez-González1, V. Jiménez-Beltrán1, N. Rodríguez-Ferreiro1, P. Flórez-Díez1, A. Suárez1,2, S. Riestra1,2

1Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain, 2Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain, 3Hospital Universitario Central de Asturias, Respiratory, Oviedo, Spain, 4Hospital Universitario Central de Asturias, Microbiology, Oviedo, Spain

P719: Update of a network meta-analysis of efficacy and safety of different intravenous iron compounds in patients with IBD and anaemia

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Aksan*1,2, H. Işık2, H. H. Radeke1,3, A. Dignass4, J. Stein1,5

1Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 2Hacettepe University, Ankara, Turkey, 3Pharmazentrum Frankfurt, Hospital of the Goethe University, Institute of Pharmacology and Toxicology, Frankfurt/Main, Germany, 4Agaplesion Markuskrankenhaus, Frankfurt/Main, Germany, 5DGD Clinics Sachsenhausen, Frankfurt/Main, Germany

P720: Efficacy of exclusive enteral nutrition for induction and partial enteral nutrition for maintenance of remission in newly diagnosed paediatric and adolescent Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Ikeda*1, T. Ogashiwa1, Y. Nakamori1, T. Mitsui1, K. Chida1, Y. Hashimoto1, Y. Tamura1, S. Maeda2, H. Kimura1, R. Kunisaki1

1Yokohama City University Medical Centre, Inflammatory Bowel Disease Center, Yokohama, Japan, 2Yokohama City University Graduate School of Medicine, Department of Gastroenterology, Yokohama, Japan

P721: Effect of thalidomide on clinical remission in adult with refractory crohn disease, a multicentre, randomised, double-blind clinical trial

ECCO '19 Copenhagen

Year: 2019
Authors:

X. Peng*1, M. Zhi1, Q. Cao2, P. Hu1, X. Gao1

1The sixth hospital affiliated to sun yat-sen university, Gastroenterology dept., Guangzhou, China, 2Run run shaw hospital affiliated of zhejiang university, Gastroenterology dept., Hangzhou, China